合成大麻素类物质所致焦虑障碍

定义

合成大麻素所致焦虑障碍的特点是，在服用合成大麻素中毒或戒断后不久出现焦虑症状（例如，忧虑或担忧、恐惧、自主神经过度唤醒的生理症状、回避行为）。症状强度或持续时间大大超过了合成大麻素中毒或合成大麻素戒断所特有的焦虑症状。合成大麻素的使用量和持续时间必须能够产生焦虑症状。这些症状不能用原发性精神障碍（例如，焦虑和恐惧相关障碍、具有突出焦虑症状的抑郁障碍）更好地解释，如果焦虑症状出现在使用合成大麻素之前，如果停止使用或停用合成大麻素后症状持续很长时间，或者，如果有其他证据表明先前存在具有焦虑症状的原发性精神障碍（例如，与合成大麻素使用无关的既往发作史）。

Synthetic cannabinoid-induced anxiety disorder is characterised by anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, avoidance behaviour) that develop during or soon after intoxication with or withdrawal from synthetic cannabinoids. The intensity or duration of the symptoms is substantially in excess of anxiety symptoms that are characteristic of Synthetic cannabinoid intoxication or Synthetic cannabinoid withdrawal. The amount and duration of synthetic cannabinoid use must be capable of producing anxiety symptoms. The symptoms are not better explained by a primary mental disorder (e.g., an Anxiety and Fear-Related Disorder, a Depressive Disorder with prominent anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset of the synthetic cannabinoid use, if the symptoms persist for a substantial period of time after cessation of the synthetic cannabinoid use or withdrawal, or if there is other evidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a history of prior episodes not associated with synthetic cannabinoid use).

索引词 可用于检索该条目的同义词与别名

• 合成大麻素类物质所致焦虑障碍